Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Genzyme sues drug firm over wrinkle treatment
Boston Globe, MA
Saturday, October 16, 2010 - 9:18am
tags:
Genzyme, Restylane, Perlane, Medicis
Johnson & Johnson Loses Risperdal Suit in Louisiana
NY Times
Saturday, October 16, 2010 - 9:14am
tags:
JNJ, Risperdal
Celgene closes $2.9B acquisition of Abraxis
Yahoo/AP
Saturday, October 16, 2010 - 9:12am
tags:
Celgene, companies, M&A
Molecular Insight Surges on Trial Results
The Street
Saturday, October 16, 2010 - 9:11am
tags:
Molecular Insight, Trofex, diagnostic imaging
Promising Data on Amgen Drug
Yahoo/Zacks
Saturday, October 16, 2010 - 9:08am
tags:
Amgen, AMG 386, ovarian cancer
Celgene Completes Acquisition of Abraxis
Yahoo
Friday, October 15, 2010 - 12:34pm
tags:
Celgene, companies
Why Pharmathene Could Go From $2 to $20
Seeking Alpha
Friday, October 15, 2010 - 12:34pm
tags:
PharmAthene, Dendreon, Emergent BioSolutions, SIGA technologies, Genzyme, Gilead Sciences, Human Genome Sciences
Blackstone and Bain Plan Bids for Pfizer Capsule Unit
NY Times, NY
Friday, October 15, 2010 - 12:31pm
tags:
private equity, Pfizer, Capsugel
When docs go electronic, they report more side effects
Fierce Pharma
Friday, October 15, 2010 - 12:30pm
tags:
electronic medical records, physicians, adverse events, side effects
Allos gets added orphan drug status for Folotyn
Yahoo/AP
Friday, October 15, 2010 - 12:29pm
tags:
orphan drugs, Allos, Folotyn, Hodgkin's lymphoma
Mylan says it is ready to start selling generic version of Merck's Cozaar and Hyzaar
Yahoo/AP
Friday, October 15, 2010 - 11:06am
tags:
generics, Merck, Mylan, Cozaar, Hyzaar
Feds Win OK To Join Rapamune Whistleblower Suit
Pharmalot
Friday, October 15, 2010 - 10:44am
tags:
whistleblowers, Rapamune, Wyeth, Pfizer, DOJ
Cheerleaders vs. Graybeards: Abbott Labs Discrimination Case Reveals War in Big Pharma
BNET Pharma
Friday, October 15, 2010 - 10:43am
tags:
age discrimination, Abbott Laboratories
Sanofi Aventis: Clouds Remain Until Genzyme Deal Is Resolved
Seeking Alpha
Friday, October 15, 2010 - 10:41am
tags:
M&A, Genzyme, Sanofi
[video] For All MannKind?
CNBC
Friday, October 15, 2010 - 10:38am
tags:
inhaled insulin, MannKind, Afrezza
Should You Let AstraZeneca Go?
Bloomberg
Friday, October 15, 2010 - 10:37am
tags:
AstraZeneca
Cubist 3Q net income rises as Cubicin sales grow
Yahoo/AP
Friday, October 15, 2010 - 10:36am
tags:
Cubist Pharmaceuticals, earnings
Sanofi MS drug data show relapses cut by 31 pct
Reuters
Friday, October 15, 2010 - 10:35am
tags:
Sanofi, MS, multiple sclerosis, teriflunomide
Drug Regulation: When Yes Means No
Forbes
Friday, October 15, 2010 - 10:29am
tags:
FDA, advisory panels
Two Surprising Big Pharmas That Show Signs of Life
Forbes
Friday, October 15, 2010 - 10:28am
tags:
Novo Nordisk, Bristol-Myers Squibb

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.